본문 바로가기
KERD
논문KCI 등재

한국인 다낭난소증후군 환자의 임상특징

The clinical characteristics of Korean women with polycystic ovary syndrome

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

주제분류내과학

초록

목적 : 다낭난소증후군(polycystic ovary syndrome, PCOS)은 만성 무배란과 안드로겐 과다를 특징으로 하는 가임 여성의 5~10%에서 발생하는 흔한 내분비질환이다. PCOS는 인슐린 저항성을 포함한 여러 가지 기전에 의한 증후군으로 그 임상양상 또한 인종에 따라 다양하게 보고되어 있다. 본 연구는 한국인 PCOS 환자의 대사 양상을 포함한 임상 특징을 규명하고자 시행되었다. 방법 : 2003년 3월부터 2006년 5월까지 European Society of Human Reproduction and Embryology (ESHRE) 기준으로 진단된 156명의 PCOS 환자와 대조군 252명을 대상으로 하였다. 대조군은 월경주기가 정상이고 직계가족 중 당뇨병, 고혈압, 불임의 병력이 없는 여성으로 하였다. 신체계측과 FG score를 산출하였고, 생식호르몬 농도, 혈청 지질농도, 내당능 상태와 인슐린 감수성 평가를 위한 75 g 경구 당부하검사를 시행하였다. 결과 : PCOS 환자 26.9%에서 비만이 6.4%에서 조모증이 있었다. 경구 당부하 검사를 시행한 결과 PCOS 환자 156명 중 1명 (0.6%)이 당뇨병이었고, 25명 (16.0%)이 내당능 장애였다. PCOS 환자의 트리글리세리드 농도, 경구 당부하검사의 0분, 30분, 60분, 90분, 120분 혈당과 30분, 60분, 90분, 120분 인슐린이 대조군에 비해 의미 있게 높았다 (p<0.05). PCOS 환자에서 대조군에 비해 인슐린 저항성 지표인 HOMA-IR이 의미 있게 높았다 (p<0.05). 결론 : 한국인 PCOS 환자는 조모증과 비만의 빈도는 다른 인종에 비해 낮았으며 인슐린 저항성은 현저하였다.

Abstract

Background : Polycystic ovary syndrome (PCOS) is characterized by chronic anovulation and hyperandrogenism and this malady arises in 5~10% of reproductive women. There may be significant ethnic and racial variations in the clinical presentation of PCOS. The current study is aimed to define the clinical characteristics, including the metabolic features, of Korean women with PCOS. Methods : We recruited 156 patients with PCOS and 252 healthy regular cycling women as controls between March 2003 and May 2006. The diagnosis of PCOS was made according to the criteria of the European Society of Human Reproduction and Embryology in 2003. The anthropometric measurements including weight, height, waist circumference, and physical examination for the modified Ferriman-Gallwey hirsutism scoring scale were performed. Reproductive hormones, blood lipids and standard 75g oral glucose tolerance tests were done to assess glucose tolerance and insulin sensitivity. Results : Twenty six percent of the women with PCOS were obese and 6.4% of them had hirsutism. One of the 156 women (0.6%) with PCOS was newly diagnosed with diabetes mellitus and 25 of them (16.0%) had impaired glucose tolerance. The triglyceride levels and plasma glucose levels at 0, 30, 60, 90 and 120 minute and the plasma insulin levels at 30, 60, 90 and 120 minutes after initiating the oral glucose tolerance test in women with PCOS were significantly higher compared to those values for the controls. The HOMA-IR was significantly higher in the women with PCOS compared to the controls, even after adjusting for age and the body mass index. Conclusions : Obesity and clinical hyperandrogenism were not frequent in Korean women with PCOS, but this population did display distinct insulin resistance.(Korean J Med 73:169-175, 2007)

참고문헌 (22)

  1. Diamanki-Kandarakis E, "A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile", J Clin Endocrinol Metab, 84, pp.4006~4011 (1999)
  2. Asuncion M, "A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain", J Clin Endocrinol Metab, 85, pp.2434~2438 (2000)
  3. Michelmore KF, "Polycystic ovaries and associated clinical and biochemical features in young women", Clin Endocrinol, 51, pp.779~786 (1999)
  4. Knochenhauer ES, "Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United Sates: a prospective study", J Clin Endocrinol Metab, 83, pp.3078~3082 (1998)
  5. Azziz R, "The prevalence and features of the polycystic ovary syndrome in an unselected population", J Clin Endocrinol Metab, 89, pp.2745~2749 (2004)
  6. Carmina E, "Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women", J Clin Endocrinol Metab, 84, pp.1897~1899 (1999)
  7. Dunaif A, "Current issues in endocrinology and metabolism: polycystic ovary syndrome" (1992), Blackwell
  8. Carmina E, "Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?", Am J Obstet Gynecol, 167, pp.1807~1812 (1992)
  9. Wijeyaratne CN, "Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?", Clin Endocrinol, 57, pp.343~350 (2002)
  10. Dunaif A, "Ethnicity and polycystic ovary syndrome are associated with independent and additive decrease in insulin action in Caribbean Hispanic women", Diabetes, 42, pp.1462~1468 (1993)
  11. The Rotterdam ESHRE, "ASRM-sponsored PCOS consensus workshop group", Revised 2003 consensus on diagnostic criteria and long health risks related to polycystic ovary syndrome, 2004, pp.19, 41~47
  12. Vermeulen A, "A critical evaluation of simple methods for the estimation of free testosterone in serum", J Clin Endocrinol Metab, 84, pp.3666~3672 (1999)
  13. "The Asia-Pacific perspecitve. Redefining obesity and its treatment" (2000)[URL]
  14. Definition, diagnosis and classification of diabetes mellitus and its complication: report of a WHO consultation: part 1. diagnosis and classification of diabetes mellitus, "World Health Organization", World Health Organization, ~ (1999)
  15. Wareham NJ, "The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion", Diabet Med, 12, pp.931~ (1995)
  16. Oh JY, "Prevalence and factor analysis of metabolic syndrome in an urban Korean population", Diabetes Care, 27, pp.2027~2032 (2004)
  17. 변은경, "서울지역 여자대학생에서 다낭성난소증후군의 유병률", Endocrinology and Metabolism, 20(2), pp.120~126 (2005), 대한내분비학회
  18. Chang WY, "Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups", Fertil Steril, 83, pp.1717~1723 (2005)
  19. Sam S, "Polycystic ovary syndrome: syndrome XX?", Trends Endocrinol Metab, 14, pp.365~370 (2003)
  20. Ehrmann DA, "Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome", Diabetes Care, 22, pp.141~146 (1999)
  21. Lergo RS, "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women", J Clin Endocrinol Metab, 84, pp.165~169 (1999)
  22. Solomon CG, "Long or highly irregular menstrual cycles as a marker for risk of type2 diabetes mellitus", JAMA, 286, pp.2421~2426 (2001)

관련 논문AI추천

다낭성 난소증후군 환자에서 비만도에 따른인슐린 저항성에 대한 연구김상만, 김진영, 양광문, 유근재, 이득주, 최규홍, 한인권대한산부인과학회 · Obstetrics & Gynecology Science2003 · 제46권 제8호다낭성난소증후군과 인슐린 저항성이병석, 황주연대한산부인과학회 · Obstetrics & Gynecology Science2006 · 제49권 제6호다낭성 난소 증후군 환자에서 메트포민 치료의효과와 인슐린 저항성구승엽, 김석현, 김정구, 문신용, 배광범, 백광현, 서창석, 손영수, 전혜원, 지병철, 최두석, 최영민, 황규리대한산부인과학회 · Obstetrics & Gynecology Science2004 · 제47권 제10호다낭성난소증후군에서 성선자극호르몬 분비 이상과 임상적, 호르몬, 대사적 특성과의 연관성서석교, 심아라, 이병석, 임경진, 전영은, 조시현, 최영미, 최영식, 황유임대한산부인과학회 · Obstetrics & Gynecology Science2011 · 제54권 제11호Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome박소연, 박수연, 이다은, 이사라, 정경아, 정혜원대한폐경학회 · 대한폐경학회지2014 · 제20권 제3호다낭성 난소증후군의 항뮐러관 호르몬에 관한 연구김영주, 박소연, 양가영, 유시연, 정경아, 정혜원대한산부인과학회 · Obstetrics & Gynecology Science2012 · 제55권 제05호

이 간행물의 다른 논문 (6건)